Free. Unsubscribe any time.
Arcutis Biotherapeutics, Inc. (ARQT)
Arcutis Biotherapeutics, Inc. filed 45 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 68 transactions and 677,386 shares. None carries the SEC's AFF10B5ONE flag; all 45 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-10, came 22 days after the one before it (2026-08-19) and reports 1 transaction against 7 in the filing before it.
- The sales it reports total 9,989 shares, 5,259 more than the 4,730 in the filing before it.
- Its 45 plan statements rank 121st of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 45 filings on file run from 2025-01-06 to 2026-09-10, and state 11 plan adoption dates, from 2024-03-05 to 2026-06-05.
Trades in Arcutis Biotherapeutics, Inc. 68
- Welgus Howard G. — 2025-01-02 · S · 10,000 shares
- Welgus Howard G. — 2025-02-03 · S · 10,000 shares
- Welgus Howard G. — 2025-03-03 · S · 10,000 shares
- Burnett Patrick — 2025-03-13 · S · 44,153 shares
- Burnett Patrick — 2025-03-13 · S · 5,008 shares
- Burnett Patrick — 2025-03-14 · S · 12,242 shares
- Watanabe Todd Franklin — 2025-03-17 · S · 1,200 shares
- Watanabe Todd Franklin — 2025-03-24 · S · 1,500 shares
- Watanabe Todd Franklin — 2025-03-25 · S · 2,171 shares
- Welgus Howard G. — 2025-04-01 · S · 10,000 shares
- Welgus Howard G. — 2025-05-01 · S · 10,000 shares
- Burnett Patrick — 2025-05-08 · S · 3,871 shares
Adoption dates in Arcutis Biotherapeutics, Inc. 11
- 2024-03-05 — stated in 5 filings
- 2024-06-14 — stated in 3 filings
- 2024-12-12 — stated in 10 filings
- 2025-03-11 — stated in 12 filings
- 2025-06-03 — stated in 3 filings
- 2025-06-05 — stated in 5 filings
- 2025-08-14 — stated in 1 filing
- 2025-11-18 — stated in 1 filing
- 2025-12-04 — stated in 1 filing
- 2026-03-13 — stated in 3 filings
- 2026-06-05 — stated in 1 filing
Results prints in Arcutis Biotherapeutics, Inc. 7
- 2025-01-13
- 2025-02-25
- 2025-05-06
- 2025-08-06
- 2025-10-28
- 2026-02-25
- 2026-08-05
Trades before a print in Arcutis Biotherapeutics, Inc. 4
- 0 days before the 2025-10-28 print — 2025-10-28 · S · Watanabe Todd · 40,000 shares
- 5 days before the 2025-05-06 print — 2025-05-01 · S · Welgus Howard G. · 10,000 shares
- 5 days before the 2025-08-06 print — 2025-08-01 · S · Welgus Howard G. · 6,110 shares
- 5 days before the 2025-08-06 print — 2025-08-01 · S · Welgus Howard G. · 3,890 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Welgus Howard G. · 10,000 shares
- 21 days before the 2026-02-25 print — 2026-02-04 · S · Burnett Patrick · 9,794 shares
- 21 days before the 2026-08-05 print — 2026-07-15 · S · Welgus Howard G. · 4,730 shares
- 22 days before the 2025-02-25 print — 2025-02-03 · S · Welgus Howard G. · 10,000 shares
- 23 days before the 2025-08-06 print — 2025-07-14 · S · Burnett Patrick · 5,750 shares
- 23 days before the 2026-02-25 print — 2026-02-02 · S · Burnett Patrick · 3,675 shares
- 23 days before the 2026-02-25 print — 2026-02-02 · S · Matsuda Masaru · 7,983 shares
- 23 days before the 2026-02-25 print — 2026-02-02 · S · Matsuda Masaru · 8,562 shares
Interval to Arcutis Biotherapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 4within 5 days
- 4within 10 days
- 0shortest, days
- 2no later print
- Welgus Howard G. 2025-05-01 · S · 5 days before the 2025-05-06 print
- Welgus Howard G. 2025-08-01 · S · 5 days before the 2025-08-06 print
- Welgus Howard G. 2025-08-01 · S · 5 days before the 2025-08-06 print
- Watanabe Todd 2025-10-28 · S · 0 days before the 2025-10-28 print · See Remarks
Adoption dates Arcutis Biotherapeutics, Inc. states
- 2024-03-05 in 5 filings
- 2024-06-14 in 3 filings
- 2024-12-12 in 10 filings
- 2025-03-11 in 12 filings
- 2025-06-03 in 3 filings
- 2025-06-05 in 5 filings
- 2025-08-14 in 1 filing
- 2025-11-18 in 1 filing
- 2025-12-04 in 1 filing
- 2026-03-13 in 3 filings
- 2026-06-05 in 1 filing
Filing text: “10b5-1 trading plan adopted on March 11, 2025”
Reported results dates on file
- 2025-01-13
- 2025-02-25
- 2025-05-06
- 2025-08-06
- 2025-10-28
- 2026-02-25
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.